Lassa Fever - Drug Pipeline Landscape, 2022 | Global Insight Services

Lassa fever is an acute viral hemorrhagic illness caused by Lassa virus, a member of the arenavirus family of viruses. It is a hemorrhagic virus that can cause bleeding without any symptoms. Lassa fever virus is a disease that is animal-borne or spread to humans from animals. It is spread to people through contact with household items, food, water, or air contaminated with the droppings or urine of infected multimammate rats (Mastomyces natalensis). The most common method of transmission is by consuming or inhaling rat urine or feces. It can also be spread through cuts and open sores. Person-to-person contact is possible via blood, tissue, secretions.

Symptoms of Lassa fever include bleeding in the gums, nose, difficulty in breathing, cough, vomiting and diarrhea, hepatitis, swollen face, hearing loss, high or low blood pressure, tremors and other CNS conditions. Diagnostic tests for Lassa fever are laboratory-based. Lassa fever is diagnosed by using enzyme-linked immunosorbent serologic assays (ELISA). These detect IgM and IgG antibodies and Lassa antigens. Reverse transcription-polymerase chain reaction (RT-PCR) can also be used in the early stages of the disease. Immunohistochemistry stains performed on tissue specimens can be used to make a post-mortem diagnosis.

Read more about Lassa Fever - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/lassa-fever-drug-pipeline-landscape-2022/

Report Highlights:

Global Insight Service's, Lassa Fever - Drug Pipeline Landscape, 2022 report provides an overview of the Lassa Fever pipeline drugs. This report covers detailed insights on Lassa Fever drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Lassa Fever pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology:

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31054/

Scope:

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Key Players:

- Inovio Pharmaceuticals
- Emergent BioSolutions Inc
- GeoVax Labs Inc
- Globavir Biosciences
- Kineta Inc.
- Medigen Inc
- Zalgen Labs LLC

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31054/

Reasons to Buy:

- Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
- Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
- Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
- Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.